Harbour Capital Advisors »

Crispr Therapeutics shares owned by Harbour Capital Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Harbour Capital Advisors from 13F filings

Historical chart of Harbour Capital Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Harbour Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Harbour Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $275k 4.2k 65.03
2023-12-31 $271k 4.3k 62.56